Changes in serum hepatitis B surface and e antigen, interferon‐inducible protein 10, and aminotransferase levels during combination therapy of immune‐tolerant chronic hepatitis B

恩替卡韦 乙型肝炎表面抗原 HBeAg 医学 免疫系统 免疫学 内科学 干扰素 抗原 病毒载量 乙型肝炎 胃肠病学 乙型肝炎病毒 病毒 拉米夫定
作者
Robert Perrillo,Hsing‐Hua Sylvia Lin,Kathleen B. Schwarz,Philip Joseph Rosenthal,Mauricio Lisker‐Melman,Raymond T. Chung,Ludmila Prokunina‐Olsson,Gavin Cloherty,Jordan J. Feld
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:76 (3): 775-787 被引量:19
标识
DOI:10.1002/hep.32400
摘要

Abstract Background and Aims Treatment of immune‐tolerant (IT) children and adults with combined peginterferon alfa‐2a and entecavir results in a decline in serum HBeAg and HBsAg concentrations but rarely results in loss of HBeAg or sustained off‐treatment response. Factors associated with declines in these viral antigens during treatment remain unexplored. Approach and Results We investigated the pattern of virologic and biochemical response in 86 participants (59 children, 27 adults) by serial quantitative measurement of HBsAg (qHBsAg), quantitative HBeAg (qHBeAg), HBV RNA, interferon‐inducible protein (IP‐10), IL‐18, and alanine aminotransferase (ALT). Each individual had previously been treated with 8 weeks of entecavir followed by 40 weeks of combined peginteferon and entecavir. We defined the interrelationships between these parameters and virologic response measured as nadir declines from baseline for HBeAg and HBsAg. The patterns of HBsAg and HBeAg decline were similar in pediatric and adult participants. Higher levels of IP‐10 were observed during treatment in participants with greater ALT elevations and greater reductions of qHBsAg and qHBeAg. Individuals with peak ALT values exceeding three times the upper limit of normal were significantly more likely to have >1 log10 decline in both viral antigens. HBV DNA became undetectable in 21 of 86 (24%) and HBV RNA in 4 of 77 (5%) during therapy, but both markers remained negative only in those who became HBsAg negative, all of whom also had ALT elevations. Conclusions Induction of IP‐10 during peginterferon treatment in adults and children in the IT phase of chronic HBV infection is associated with ALT elevations and decline in viral antigens, suggesting a degree of interferon‐inducible viral control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
沐木发布了新的文献求助30
2秒前
yrz完成签到,获得积分20
3秒前
斯文败类的应助被xwx采纳,获得10
4秒前
徐丹枫发布了新的文献求助10
4秒前
4秒前
乌龙茶发布了新的文献求助10
4秒前
我是老大的应助被科研通管家采纳,获得10
4秒前
深情安青的应助被科研通管家采纳,获得10
5秒前
5秒前
FashionBoy的应助被科研通管家采纳,获得50
5秒前
情怀的应助被科研通管家采纳,获得10
5秒前
Hase的应助被科研通管家采纳,获得30
5秒前
秋风的应助被科研通管家采纳,获得10
5秒前
华仔的应助被科研通管家采纳,获得10
5秒前
酷波er的应助被科研通管家采纳,获得10
5秒前
CipherSage的应助被科研通管家采纳,获得20
6秒前
勤奋一一的应助被科研通管家采纳,获得10
6秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
6秒前
6秒前
王英霖的应助被科研通管家采纳,获得20
6秒前
秋风的应助被科研通管家采纳,获得20
6秒前
syvshc的应助被科研通管家采纳,获得10
6秒前
李爱国的应助被科研通管家采纳,获得10
6秒前
科研通AI2S的应助被科研通管家采纳,获得10
7秒前
Luna666完成签到,获得积分10
7秒前
乐乐的应助被科研通管家采纳,获得10
7秒前
7秒前
wanci的应助被科研通管家采纳,获得50
7秒前
7秒前
丁亦竹发布了新的文献求助100
8秒前
能干灯泡发布了新的文献求助10
9秒前
赘婿的应助被观山青采纳,获得10
9秒前
传奇3的应助被平常的路人采纳,获得10
9秒前
我家电脑完成签到 ,获得积分10
10秒前
11秒前
科目三的应助被XPR采纳,获得10
11秒前
eeeee完成签到,获得积分10
12秒前
木子发布了新的文献求助10
13秒前
15秒前
memebao完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598